# Axio Biosolutions

**Canonical:** https://apis.io/providers/axio/  
**Website:** https://axiobio.com  
**APIs profiled:** 0

Axio Biosolutions Private Limited is a medical technology manufacturer headquartered in Ahmedabad, Gujarat, India, focused on advanced chitosan-based solutions for bleeding control, trauma care, surgical care, and advanced wound care. Its Axiostat hemostatic dressings deliver rapid hemostasis for emergency, military, and surgical bleeding, while its MaxioCel microfiber gelling wound dressings support wound healing, exudate management, and infection risk reduction across chronic and acute wounds. Axio operates its own manufacturing and quality systems and holds FDA and CE regulatory certifications. The company publishes no public API or developer platform; this profile captures its public web and discovery surface.

## Kin Score — 7.1 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 7.1).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 6.5 |
| Commercial Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Axio Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Manufacturing, Medical Devices, MedTech, Healthcare, Wound Care, Hemostatic Dressings, Trauma Care

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/axio/). Scores are computed from the provider's own public artifacts under a published rubric.